Today, on 21 January 2025, an extraordinary general meeting was held in DanCann Pharma A/S (company reg. no. (CVR) 39426005) (the “Company”). On the extraordinary general meeting, it was resolved to change the nominal value of the shares of the Company by way of a reverse share split in the …
